Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

GADD45B anticorps (Middle Region)

GADD45B Reactivité: Humain, Souris, Rat WB Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN634503
  • Antigène Voir toutes GADD45B Anticorps
    GADD45B (Growth Arrest and DNA-Damage-Inducible, beta (GADD45B))
    Épitope
    • 16
    • 6
    • 3
    • 2
    • 1
    Middle Region
    Reactivité
    • 35
    • 22
    • 6
    • 4
    • 2
    • 1
    • 1
    • 1
    • 1
    Humain, Souris, Rat
    Hôte
    • 35
    Lapin
    Clonalité
    • 35
    Polyclonal
    Conjugué
    • 8
    • 4
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp GADD45B est non-conjugé
    Application
    • 24
    • 14
    • 13
    • 13
    • 11
    • 6
    • 4
    • 3
    • 3
    • 2
    • 2
    Western Blotting (WB)
    Specificité
    GADD45 B antibody was raised against the middle region of GADD45
    Purification
    Affinity purified
    Immunogène
    GADD45 B antibody was raised using the middle region of GADD45 corresponding to a region with amino acids FCCDNDINIVRVSGMQRLAQLLGEPAETQGTTEARDLHCLLVTNPHTDAW
    Top Product
    Discover our top product GADD45B Anticorps primaire
  • Indications d'application
    WB: 0.25 µg/mL
    Optimal conditions should be determined by the investigator.
    Commentaires

    GADD45B Blocking Peptide, catalog no. 33R-2851, is also available for use as a blocking control in assays to test for specificity of this GADD45B antibody

    Restrictions
    For Research Use only
  • Format
    Lyophilized
    Reconstitution
    Lyophilized powder. Add distilled water for a 1 mg/mL concentration of GADD40 antibody in PBS
    Concentration
    Lot specific
    Buffer
    PBS
    Conseil sur la manipulation
    Avoid repeated freeze/thaw cycles.
    Dilute only prior to immediate use.
    Stock
    4 °C/-20 °C
    Stockage commentaire
    Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
  • Antigène
    GADD45B (Growth Arrest and DNA-Damage-Inducible, beta (GADD45B))
    Autre désignation
    GADD45B (GADD45B Produits)
    Synonymes
    anticorps GADD45BETA, anticorps MYD118, anticorps AI323528, anticorps Myd118, anticorps CS131, anticorps cb196, anticorps gadd45b, anticorps gadd45b2, anticorps sb:cb196, anticorps zgc:73104, anticorps gadd45beta, anticorps wu:fa92d10, anticorps wu:fa98h12, anticorps wu:fk65h03, anticorps zgc:111973, anticorps gadd45b1, anticorps gadd45bl, anticorps zgc:112453, anticorps growth arrest and DNA damage inducible beta, anticorps growth arrest and DNA-damage-inducible 45 beta, anticorps growth arrest and DNA-damage-inducible, beta, anticorps growth arrest and DNA-damage-inducible, beta a, anticorps growth arrest and DNA-damage-inducible, beta b, anticorps GADD45B, anticorps Gadd45b, anticorps gadd45ba, anticorps gadd45bb
    Sujet
    GADD45B is a member of a group of genes whose transcript levels are increased following stressful growth arrest conditions and treatment with DNA-damaging agents. The genes in this group respond to environmental stresses by mediating activation of the p38/JNK pathway. This activation is mediated via their proteins binding and activating MTK1/MEKK4 kinase, which is an upstream activator of both p38 and JNK MAPKs. The function of these genes or their protein products is involved in the regulation of growth and apoptosis. These genes are regulated by different mechanisms, but they are often coordinately expressed and can function cooperatively in inhibiting cell growth.
    Poids moléculaire
    18 kDa (MW of target protein)
    Pathways
    Cycle Cellulaire
Vous êtes ici:
Support technique